Since the outbreak of SARS-CoV-2. antigenicity concerns continue to linger with emerging mutants. As recent variants have shown decreased reactivity to previously determined monoclonal antibodies (mAbs) or sera. monitoring the antigenicity change of circulating mutants is urgently needed for vaccine effectiveness. https://www.spidertattooz.com/